Skip to main content

3 Result(s)

within C. R. Lindsay Remove this filter

and

  1. Article

    Open Access

    Toxicity with small molecule and immunotherapy combinations in non-small cell lung cancer

    Treatment stratification in stage IV NSCLC is guided by identification of oncogene driver mutations. Actionable mutations with current licenced therapeutic agents include epidermal growth factor receptor (EGFR...

    H. Adderley, F. H. Blackhall, C. R. Lindsay in Cancer Immunology, Immunotherapy (2021)

    Download PDF (529 KB) View Article

  2. Article

    Open Access

    Vimentin and Ki67 expression in circulating tumour cells derived from castrate-resistant prostate cancer

    High circulating tumor cell (CTC) counts are associated with poor prognosis in advanced prostate cancer, and recently CTC number was suggested to be a surrogate for survival in metastatic castrate-resistant pr...

    C. R. Lindsay, S. Le Moulec, F. Billiot, Y. Loriot, M. Ngo-Camus, P. Vielh… in BMC Cancer (2016)

    Download PDF (1199 KB) View Article

  3. No Access

    Article

    Regulation of mitosis and taxane response by Daxx and Rassf1

    Current theories suggest that mitotic checkpoint proteins are essential for proper cellular response to taxanes, a widely used family of chemotherapeutic compounds. We recently showed that absence or depletion...

    S Giovinazzi, C R Lindsay, V M Morozov, E Escobar-Cabrera, M K Summers, H S Han… in Oncogene (2012)